# Oral Dosage Form New Animal Drugs; Deracoxib
> **Food and Drug Administration** · Final rule. · Published 2012-01-26 · Effective 2012-01-26 · 77 FR 3927
## Document
- **Document number:** 2012-1622
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 77 FR 3927
- **CFR reference:** 21 CFR 520
- **Publication date:** 2012-01-26
- **Effective date:** 2012-01-26
- **HHS docket:** Docket No. FDA-2011-N-0003
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health U.S., Inc. The supplemental NADA provides for veterinary prescription use of deracoxib tablets in dogs for the control of postoperative pain and inflammation associated with dental surgery and the addition of a 12-milligram (mg) size tablet.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2012/01/26/2012-1622/oral-dosage-form-new-animal-drugs-deracoxib)
---
*AI Analytics · CC0 1.0*